These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 35384179)

  • 21. Psychotropic medication use for adults and older adults with intellectual disability; selective review, recommendations and future directions.
    Deutsch SI; Burket JA
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jan; 104():110017. PubMed ID: 32544599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Practical guidelines for prescribing psychotropic medication to people with intellectual disability].
    de Kuijper G; Degraeve G; Zinkstok JR
    Tijdschr Psychiatr; 2019; 61(11):786-791. PubMed ID: 31907889
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psychotropic Use Among Youths With Intellectual and Developmental Disabilities.
    McLaren JL; Lichtenstein JD; Metcalfe JD; Charlot LR; Drake RE; Beasley JB
    Psychiatr Serv; 2021 Sep; 72(9):988-997. PubMed ID: 33882691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of psychotropic medications in adults with intellectual disability: a scoping review.
    Costello A; Hudson E; Morrissey S; Sharma D; Kelly D; Doody O
    Ann Med; 2022 Dec; 54(1):2486-2499. PubMed ID: 36120887
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence and patterns of antipsychotic use and their associations with mental health and problem behaviours among older adults with intellectual disabilities.
    O'Dwyer C; McCallion P; Henman M; McCarron M; O'Leary E; Burke E; O'Connell J; O'Dwyer M
    J Appl Res Intellect Disabil; 2019 Jul; 32(4):981-993. PubMed ID: 31038275
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Psychotropic medication use in adults with intellectual disability in Queensland, Australia, from 1999 to 2015: a cohort study.
    Song M; Ware R; Doan TN; Harley D
    J Intellect Disabil Res; 2020 Jan; 64(1):45-56. PubMed ID: 31478300
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Psychotropic drugs and mental retardation: 2. A comparison of psychoactive drug use before and after discharge from hospital to community.
    Thinn K; Clarke DJ; Corbett JA
    J Ment Defic Res; 1990 Oct; 34 ( Pt 5)():397-407. PubMed ID: 1979993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polypharmacy in the treatment of subjects with intellectual disability.
    Häβler F; Thome J; Reis O
    J Neural Transm (Vienna); 2015 Aug; 122 Suppl 1():S93-100. PubMed ID: 24858727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors of Psychotropic Polypharmacy Among Outpatients With Psychiatric Disorders and Intellectual Disability.
    Lunsky Y; Modi M
    Psychiatr Serv; 2018 Feb; 69(2):242-246. PubMed ID: 29089006
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Physicians' reasons not to discontinue long-term used off-label antipsychotic drugs in people with intellectual disability.
    de Kuijper GM; Hoekstra PJ
    J Intellect Disabil Res; 2017 Oct; 61(10):899-908. PubMed ID: 28560761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of psychotropic medication in people with a learning disability.
    Jenkins R
    Br J Nurs; 2000 Jul 13-26; 9(13):844-50. PubMed ID: 11261057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improving knowledge of psychotropic prescribing in people with Intellectual Disability in primary care.
    Shankar R; Wilcock M
    PLoS One; 2018; 13(9):e0204178. PubMed ID: 30216381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety of antipsychotics in people with intellectual disability.
    Frighi V; Stephenson MT; Morovat A; Jolley IE; Trivella M; Dudley CA; Anand E; White SJ; Hammond CV; Hockney RA; Barrow B; Shakir R; Goodwin GM
    Br J Psychiatry; 2011 Oct; 199(4):289-95. PubMed ID: 21816867
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psychopharmacoepidemiology of mental retardation: 1966 to 1995.
    Singh NN; Ellis CR; Wechsler H
    J Child Adolesc Psychopharmacol; 1997; 7(4):255-66. PubMed ID: 9542696
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiepileptic drugs, occurrence of seizures and effect of co-administration of potential seizure threshold-lowering psychotropic drugs in adults with intellectual disability who have epilepsy.
    Monaghan R; O'Dwyer M; Luus R; Mulryan N; McCallion P; McCarron M; Henman MC
    J Appl Res Intellect Disabil; 2021 May; 34(3):818-829. PubMed ID: 33530136
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiseizure medications prescribing for behavioural and psychiatric concerns in adults with an intellectual disability living in England.
    Branford D; Sun JJ; Shankar R
    Br J Psychiatry; 2023 May; 222(5):191-195. PubMed ID: 36786124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adverse events and the relation with quality of life in adults with intellectual disability and challenging behaviour using psychotropic drugs.
    Scheifes A; Walraven S; Stolker JJ; Nijman HL; Egberts TC; Heerdink ER
    Res Dev Disabil; 2016; 49-50():13-21. PubMed ID: 26647003
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psychotropic and anticonvulsant drug use by mentally retarded adults across community residential and vocational placements.
    Martin JE; Agran M
    Appl Res Ment Retard; 1985; 6(1):33-49. PubMed ID: 2859836
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An Open-Label Discontinuation Trial of Long-Term, Off-Label Antipsychotic Medication in People With Intellectual Disability: Determinants of Success and Failure.
    de Kuijper GM; Hoekstra PJ
    J Clin Pharmacol; 2018 Nov; 58(11):1418-1426. PubMed ID: 29920689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiepileptic drugs with mood stabilizing properties and their relation with psychotropic drug use in institutionalized epilepsy patients with intellectual disability.
    Leunissen CL; de la Parra NM; Tan IY; Rentmeester TW; Vader CI; Veendrick-Meekes MJ; Aldenkamp AP
    Res Dev Disabil; 2011; 32(6):2660-8. PubMed ID: 21752594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.